Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
81.1
Signal Score
✓ FDA Inspections (3)
○ Clinical Trials
○ SEC Filings
✓ Press (1)
✓ EMA GMP (10)
○ MHRA GMP
Quick Facts: Corden Pharma
- Signal Score
- 81.1/100 (as of 2026-09-07)
- Quality Compliance
- 98.9/100
- Headquarters
- Plankstadt, DE · Caponago, IT · Boulder, CO
- Modalities
- mRNA, Oligonucleotide, Biologics
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Corden Pharma
Manufactured lipids for BioNTech COVID vaccine.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
98.9
FDA Inspections3 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-11-14)
EMA GMP Certificates10 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, Oligonucleotide, Biologics
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
68.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
63.0
Profile-based capacity assessment
Recent Press1 articles
Corden Pharma FDA Inspection History
2025-11
2025-10
2025-03
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-11-14 |
Corden Pharma Colorado, Inc.
Boulder, Colorado
Facility-linked
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2025-10-15 |
Corden Pharma GmbH
Plankstadt
Facility-linked
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2025-03-28 |
Corden Pharma S.p.A.
Caponago
Facility-linked
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 07, 2026
Attribution not established
(1)
These records are excluded from this company’s established evidence
because their attribution is unresolved. This describes an evidence-linking
limitation, not an assessment of the underlying regulatory findings.
| Source | Establishment named by the regulator | Location | Identifier |
|---|---|---|---|
| FDA inspection | Carecam International, Inc. | Fairfield, New Jersey | FDA/FEI=3000215814 |
Source records retained verbatim · attribution not established
Corden Pharma EMA GMP Compliance 10 certificates
2025-10
2025-10
2025-05
2025-03
2025-03
2025-03
2025-03
2025-03
2025-03
2025-03
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_BW_01_GMP_2025_0261 | Corden Pharma GmbH | Germany | 2025-10-15 | COMPLIANT |
| DE_BW_01_GMP_2025_0260 | Corden Pharma GmbH | Germany | 2025-10-15 | COMPLIANT |
| 2025_HPF_FR_090 | Corden Pharma Chenove | France | 2025-05-15 | COMPLIANT |
| IT/80/H/2025 | Corden Pharma S.p.A. | Italy | 2025-03-28 | COMPLIANT |
| IT/121/H/2026 | Corden Pharma S.p.A. | Italy | 2025-03-28 | COMPLIANT |
| IT/148/H/2026 | Corden Pharma S.p.A. | Italy | 2025-03-28 | COMPLIANT |
| F022/S1/MH/001/2026 | Corden Pharma Lisbon S.A. | Portugal | 2025-03-21 | COMPLIANT |
| F022/S2/MH/001/2026 | Corden Pharma Lisbon S.A. | Portugal | 2025-03-21 | COMPLIANT |
| F022/S2/ME/001/2026 | Corden Pharma Lisbon S.A. | Portugal | 2025-03-21 | COMPLIANT |
| F022/S1/ME/001/2026 | Corden Pharma Lisbon S.A. | Portugal | 2025-03-21 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Oct 07, 2026
Recent News 1 articles
CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion - CHEManager
CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion CHEManager.
Frequently Asked Questions About Corden Pharma
How many FDA inspections does Corden Pharma have on record?
CDMO Signal tracks 3 FDA inspections for Corden Pharma, sourced from the FDA inspection database. See the full inspection history above.
Has Corden Pharma received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Corden Pharma.
Does Corden Pharma hold EMA or MHRA GMP certificates?
CDMO Signal tracks 10 EMA GMP certificates for Corden Pharma.
What is Corden Pharma's CDMO Signal Score?
Corden Pharma has a Signal Score of 81/100, based on quality, operations, financial stability, and capacity data.
Evaluating Corden Pharma for a manufacturing program?
Use the free AI matchmaker to compare Corden Pharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.4
mRNA, Oligonucleotide, Biologics
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 84.8
AAV, mRNA/LNP, Biologics, mRNA
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy